MedPath

Analysis on the Distribution of TCM Syndromes in convalescent novel coronavirus pneumonia (COVID-19) patients

Phase 1
Conditions
ovel Coronavirus Pneumonia (COVID-19)
Registration Number
ITMCTR2000003991
Lead Sponsor
Beijing University of Chinese Medicine Third Affiliated Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. According to the COVID-19 diagnosis and treatment Plan-trial Seventh Edition jointly issued by the State Health Commission and the State Administration of traditional Chinese Medicine on March 3, 2020, it is in line with COVID-19 's convalescent patients;
2. Informed consent to this study, volunteer to participate in the study.

Exclusion Criteria

1. Those who are participating in other clinical trials;
2. Those who cannot cooperate with the original serious diseases such as brain, heart, liver, kidney and hematopoietic system, malignant tumors and mental and neurological disorders can not cooperate.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Syndrome distribution law;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath